PASCALE ADAM 4
4 · HEMISPHERX BIOPHARMA INC · Filed Oct 19, 2018
Insider Transaction Report
Form 4
Pascale Adam
Chief Accounting Officer
Transactions
- Award
Options to buy Common Stock
2018-10-17+94,697→ 94,697 totalExercise: $0.22From: 2018-10-17Exp: 2028-10-17→ Common Stock (94,697 underlying)
Footnotes (1)
- [F1]This option is being issued to senior management in exchange for a voluntary 50% deferral in salary.